Sign in

CIK 0001719406

  • Non-accelerated filer
  • Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822844431
Phone
+1 484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 4 Open-market buy Chief Scientist bought 100,000 shares at $58.00 ($5,800,000)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Exercise or conversion Director acquired 18,300 shares (option exercise)
  5. 4 Gift 10% owner gave 869,188 shares (gift)
  6. 4 Open-market sale General Counsel & Secretary sold 33,715 shares at $13.11 ($442,004)
  7. 4 Open-market sale Chief Comm. & Patient Officer sold 40,000 shares at $11.76 ($470,400)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 43,093 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 14,817,329 shares (grant or award)
  11. 4 Grant or award 10% owner acquired 13,971,864 shares (grant or award)
  12. 4 Grant or award Director acquired 1,644,793 shares (grant or award)
  13. 4 Grant or award Director acquired 41,686 shares (grant or award)
  14. 4 Grant or award Director acquired 13,168 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 432,750 shares (grant or award)
  17. 4 Grant or award General Counsel & Secretary acquired 6,320 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 5 · 84 filings